Page 20 - 南京医科大学学报自然科学版
P. 20
第43卷第3期
·310 · 南 京 医 科 大 学 学 报 2023年3月
LINC01518 的表达可正向提升 IL⁃17 诱导 H1299 细 Am J Cancer Res,2021,11(4):1572-1585
胞增殖的能力。 [9] CHENG G,LI Y,LIU Z,et al. LncRNA PSMA3⁃AS1 pro⁃
LncRNA调控细胞生物学行为的机制之一是其 motes the progression of non ⁃ small cell lung cancer
能吸附miRNA影响靶基因的表达,故其在肿瘤等疾 through targeting miR⁃ 17⁃5p/PD⁃L1[J]. Adv Clin Exp
Med,2021,30(10):1043-1050
病的发生与发展中发挥了重要作用 [8-10,12-13,15-18] 。由
[10] XING Z,ZHANG Z,GAO Y,et al. The lncRNA
于 LINC01518 可竞争结合某些 miRNA 来影响细胞
LINC01194/miR ⁃ 486 ⁃ 5p axis facilitates malignancy in
的某些病变 [12-13] ,故设想在 NSCLC 发病和进展过程
non⁃small cell lung cancer via regulating CDK4[J]. Onco
中,LINC01518 的表达上调或许也能通过结合相应 Targets Ther,2020,13:3151-3163
的miRNA促进IL⁃17诱导的肿瘤细胞增殖反应。不 [11] WANG W W,WEI C G,LI P,et al. Integrative analysis of
过,这一推测还有待后续进一步对 LINC01518 的细 mRNA and lncRNA profiles identified pathogenetic
胞定位和功能研究等加以验证。 lncRNAs in esophageal squamous cell carcinoma[J].
Gene,2018,661:169-175
[参考文献]
[12] ZHANG D H,ZHANG H F,WANG X L,et al. LINC01518
[1] HERBST R S,MORGENSZTERN D,BOSHOFF C. The knockdown inhibits tumorigenicity by suppression of
biology and management of non small cell lung cancer PIK3CA/Akt pathway in oesophageal squamous cell carci⁃
[J]. Nature,2018,553(7689):446-454 noma[J]. Artif Cells Nanomed Biotechnol,2019,47(1):
[2] RICE S J,LIU X,ZHANG J H,et al. Advanced NSCLC 4284-4292
patients with high IL⁃ 6 levels have altered peripheral T [13] KONG N,BAO Y,ZHAO H,et al. Long noncoding RNA
cell population and signaling[J]. Lung Cancer Amster⁃ LINC01518 modulates proliferation and migration in TGF⁃
dam Neth,2019,131:58-61 β1⁃treated human tenon capsule fibroblast cells through
[3] KWIECIEN I,STELMASZCZYK⁃EMMEL A,POLUBIEC⁃ the regulation of hsa⁃miR⁃216b⁃5p[J]. Neuromolecular
KOWNACKA M,et al. Elevated regulatory T cells,sur⁃ Med,2022,24(2):88-96
face and intracellular CTLA⁃4 expression and interleukin⁃ [14] YOJIRO K,NATSUMI M,TAKAHIRO W,et al. OIP5 ⁃
17 in the lung cancer microenvironment in humans[J]. AS1 promotes proliferation of non⁃small⁃cell lung cancer
Cancer Immunol Immunother,2017,66(2):161-170 and head and neck squamous cell carcinoma cells[J].
[4] WANG B,ZHAO C H,SUN G,et al. IL⁃17 induces the Cancer Genom Proteom,2021,18(4):543-548
proliferation and migration of glioma cells through the ac⁃ [15] PENG X,WEI F,HU X. Long noncoding RNA DLGAP1⁃
tivation of PI3K/Akt1/NF⁃κB⁃p65[J]. Cancer Lett,2019, AS1 promotes cell proliferation in hepatocellular carcino⁃
447:93-104 ma via sequestering miR ⁃ 486 ⁃ 5p[J]. J Cell Biochem,
[5] XIANG T,LONG H,HE L,et al. Interleukin⁃17 produced 2020,121(2):1953-1962
by tumor microenvironment promotes self ⁃ renewal of [16] CHEN W H,WANG L F,LI X Y,et al. LncRNA SNHG17
+
CD133 cancer stem⁃like cells in ovarian cancer[J]. On⁃ regulates cell proliferation and invasion by targeting miR⁃
cogene,2015,34(2):165-176 338⁃3p/SOX4 axis in esophageal squamous cell carcinoma
[6] ZHAO C,LI Y,ZHANG W,et al. IL17 induces NSCLC [J]. Cell Death Dis,2021,12(9):806
A549 cell proliferation via the upregulation of HMGA1, [17] WANG J,YU Z Y,WANG J,et al. LncRNA NUTM2A⁃
resulting in an increased cyclin D1 expression[J]. Int J AS1 positively modulates TET1 and HIF⁃1A to enhance
Oncol,2018,52(5):1579-1592 gastric cancer tumorigenesis and drug resistance by spong⁃
[7] GE B H,ZHANG X,ZHOU W,et al. LINC00265 promotes ing miR⁃376a[J]. Cancer Med,2020,9(24):9499-9510
metastasis and progression of hepatocellular carcinoma by [18] YANG Y,YU Q,LI B,et al. BBOX1⁃AS1 accelerates gas⁃
interacting with E2F1 at the promoter of CDK2[J]. Cell J, tric cancer proliferation by sponging miR⁃3940⁃3p to up⁃
2022,24(6):294-301 regulate BIRC5 expression[J]. Dig Dis Sci,2021,66(4):
[8] ZHENG G L,LIU Y L,YAN Z X,et al. Elevated LOXL2 1054-1062
expression by LINC01347/miR⁃328⁃5p axis contributes to [收稿日期] 2022-07-29
5 ⁃ FU chemotherapy resistance of colorectal cancer[J]. (本文编辑:陈汐敏)